$INVH

Evercore ISI Adjusts PT on Invitation Homes to $33 From $34, Maintains Outperform Rating

Evercore ISI reduced its price target on Invitation Homes from $34 to $33 but maintained an Outperform rating. Mizuho upgraded the stock to Outperform with a new target of $32. The company's stock has declined 3.17% over the past year.

Original reporting
Published Sep 21, 2026, 10:32 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 21, 2026, 11:37 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$INVH
Bearish
medium confidence
Mentioned
$INVH
Relevance
7/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

$INVHBearishMed
01

Why it matters

The target reduction reflects a modestly weaker outlook for INVH, potentially prompting short‑term price adjustments.

02

Market read

Analyst price‑target changes are a common catalyst for REIT price movement; traders may adjust positions accordingly.

03

What to watch

Recent lease‑up activity and low vacancy rates were not addressed in the target cut.

Relevance 7/10Novelty 7/10Timing: pre‑market

Background

Evercore ISI regularly updates price targets based on valuation, EPS revisions, and visibility metrics.

Company-level read

Ticker impact

$INVHBearishMedium confidence
Context

Evercore ISI lowered INVH's price target to $33 from $34 while keeping an Outperform rating.

Expected impact

Potential short‑term price dip of 2‑4% as investors reassess valuation.

Evidence & confidence

Price‑target cuts are a direct catalyst; the magnitude is modest but can trigger sell pressure in a thinly‑traded REIT.

Market effects

May signal broader concerns about the single‑family rental market outlook.

Limited to U.S. REIT investors; no immediate global effect.

Low

Counterpoint

The downgrade could be an overreaction; fundamentals remain strong, offering a buying opportunity.

Key entities

  • Evercore ISI

    Equity research firm providing the rating and price‑target update.

  • Invitation Homes Inc.

    U.S. REIT focused on single‑family rental homes.

Related articles

$INVHMed

Invitation Homes Inc. (INVH): Results of Operations and Financial Condition

Invitation Homes Inc. (INVH) filed an SEC Form 8-K — Results of Operations and Financial Condition. Table of Contents Earnings Press Release 3 Consolidated Financial Statements 9 Schedule 1: Reconciliation of FFO, Core FFO, and AFFO 11 Schedule 2: Capital Structure Information 12 Schedule 3: Same Store Portfolio Core Operating Detail 16 Schedule 4: Home Characteristics by Marke

$INVHMedAI 9/10

Is Invitation Homes (INVH) the Best Residential REIT to Buy in 2026?

Raymond James upgraded Invitation Homes (INVH) to Outperform from Market Perform on May 18, setting a $32 price target, citing improving single-family rental leasing demand and a House version of the 21st Century ROAD to Housing Act viewed as more favorable. BofA raised its INVH target to $35 from $34 and kept Neutral. INVH reported Q1 FFO of 48c/share and revenue of $734M; same-store NOI fell 0.3% and occupancy dropped to 96.3%.

$CLMed

Piper Sandler cuts Colgate-Palmolive stock price target on cost pressures

Piper Sandler reduced its price target for Colgate-Palmolive (CL) to $95 from $98, citing cost pressures from elevated oil prices and inventory headwinds. The firm maintained an Overweight rating and a 2026 EPS estimate of $3.85, but lowered its 2027 EPS estimate to $4.12 from $4.23. CL trades at $87.47 with a P/E ratio of 34.6 and a gross profit margin of 60%. Other analysts have maintained positive outlooks, with RBC and UBS setting higher price targets.

$DYMed

KeyBanc raises Dycom Industries stock price target on growth outlook

KeyBanc raised its price target for Dycom Industries (NYSE:DY) to $429 from $423, citing growth outlook and meetings with management. The stock is down 48% from its 52-week high but is considered undervalued. Other analysts have mixed views, with UBS reiterating a Buy rating and Raymond James lowering its target. Dycom reported 38% revenue growth over the last year.

MedAI 8/10

85% of Nscale’s $103B of contracts are with Microsoft and Anthropic

Nscale revealed that 85% of its $103B contracts are with Microsoft (MSFT) and Anthropic, including $43.8B with MSFT and $44.6B with Anthropic. The company acknowledged concentration risk and reported a net loss of $1.02B on $140.6M sales for H1. Nvidia (NVDA) is a major shareholder and supplier. Nscale aims for a $35B valuation in its upcoming IPO.

$MSTRMedAI 8/10

'A little more orange': Strategy buys 950 bitcoin for $76 million, bringing total holdings to 846,000 BTC

Strategy bought 950 BTC for $75.7M at $79,670 each, increasing its holdings to 846,000 BTC. The purchases were funded by the company's USD Cash reserve. Strategy's total BTC holdings are worth around $71.9B, bought at an average price of $75,416 each. The company also repurchased 1.77M STRC preferred shares for $174M. As of Sept. 20, its USD Reserve and USD Cash balances were $5.04B and $1.05B, respectively.